TP53 and neoplasm: The TIGAR, which was discovered as a p53 target gene, has been gradually recognized in recent years with the gradual development of research, and its duality in tumors has also gradually been recognized; that is, the TIGAR can inhibit the survival and proliferation of tumor cells by reducing glycolysis.